{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T17:34:57Z","timestamp":1780853697928,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejim.2014.01.001","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T22:16:27Z","timestamp":1389996987000},"page":"276-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The relationship between secondary hyperparathyroidism and thyroid cancer in end stage renal disease: A population based cohort study"],"prefix":"10.1016","volume":"25","author":[{"given":"Shih-Yi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Yen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fung-Chang","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2014.01.001_bb0005","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2014.01.001_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2014.01.001_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2014.01.001_bb0020","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/ndt\/gfr464","article-title":"Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan","volume":"27","author":"Lin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2014.01.001_bb0025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/jjco\/hyr051","article-title":"The association between malignancy and end-stage renal disease in Taiwan","volume":"41","author":"Liang","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejim.2014.01.001_bb0135","doi-asserted-by":"crossref","first-page":"e44675","DOI":"10.1371\/journal.pone.0044675","article-title":"Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan","volume":"7","author":"Chung","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2014.01.001_bb0035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0272-6386(97)90459-5","article-title":"Hyperparathyroidism in the hemodialysis population: a survey of 612 patients","volume":"29","author":"Salem","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2014.01.001_bb0040","first-page":"S90","article-title":"Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation","volume":"62","author":"Nishizawa","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ejim.2014.01.001_bb0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.ajkd.2011.08.009","article-title":"CKD-mineral and bone disorder: core curriculum 2011","volume":"58","author":"Moorthi","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2014.01.001_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2215\/CJN.04650512","article-title":"The case for routine parathyroid hormone monitoring","volume":"8","author":"Sprague","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2014.01.001_bb0055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9610(99)00194-4","article-title":"Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism","volume":"178","author":"Yasunaga","year":"1999","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejim.2014.01.001_bb0140","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/cncr.10846","article-title":"Hyperparathyroidism and subsequent cancer risk in Denmark","volume":"95","author":"Pickard","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2014.01.001_bb0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ijc.20155","article-title":"Hyperparathyroidism and subsequent incidence of breast cancer","volume":"110","author":"Michels","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejim.2014.01.001_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.1.01261","article-title":"The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy","volume":"14","author":"Nilsson","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejim.2014.01.001_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ejim.2014.01.001_bb0080","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ard.2009.116178","article-title":"Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study","volume":"69","author":"Kang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2014.01.001_bb0085","first-page":"427","article-title":"Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: a continuing dilemma","volume":"60","author":"Fedorak","year":"1994","journal-title":"Am Surg"},{"key":"10.1016\/j.ejim.2014.01.001_bb0090","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.surg.2011.07.046","article-title":"Primary hyperparathyroidism with a history of head and neck irradiation: the consequences of associated thyroid tumors","volume":"150","author":"Wilson","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2014.01.001_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cancergencyto.2010.09.006","article-title":"Solid tumors associated with multiple endocrine neoplasias","volume":"203","author":"Almeida","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ejim.2014.01.001_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/418695","article-title":"Effects of parathyroid hormone on immune function","volume":"41865","author":"Geara","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.ejim.2014.01.001_bb0105","first-page":"22","article-title":"Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?","volume":"54","author":"Tzanno-Martins","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ejim.2014.01.001_bb0145","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2014.01.001_bb0150","first-page":"19","article-title":"Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism","author":"Lin","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2014.01.001_bb0120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/14656566.2013.783017","article-title":"Hyperparathyroidism in chronic kidney disease patients: an update on current pharmacotherapy","volume":"14","author":"Fukagawa","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2014.01.001_bb0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S0022215111002908","article-title":"Use of minimally invasive parathyroidectomy techniques in sporadic primary hyperparathyroidism: systematic review","volume":"126","author":"Gracie","year":"2012","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.ejim.2014.01.001_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/jca.3.1","article-title":"Preoperative thyroid ultrasound is indicated in patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"3","author":"Arciero","year":"2012","journal-title":"J Cancer"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T03:53:24Z","timestamp":1538884404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620514000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0953620514000028"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.01.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between secondary hyperparathyroidism and thyroid cancer in end stage renal disease: A population based cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}